Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: a clinical trial by Masao Koda, Shiro Imagama, Hiroaki Nakashima, Sadayuki Ito, Naoki Segi, Jun Ouchida, Kota Suda, Satoko Harmon Matsumoto, Miki Komatsu, Toshiki Endo, Shinsuke Suzuki, Satoshi Inami, Haruki Ueda, Masayuki Miyagi, Gen Inoue, Masashi Takaso, Keiji Nagata, Hiroshi Yamada, Naosuke Kamei, Toshio Nakamae, Hidenori Suzuki, Norihiro Nishida, Masahiro Funaba, Gentaro Kumagai, Takeo Furuya, Yu Yamato, Toru Funayama, Hiroshi Takahashi, Masashi Yamazaki

Get full text